PharVision Advisers’s Groupon GRPN Stock Holding History

PharVision Advisers’s Portfolio GRPN Stock Details GRPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,696	Closed	-$273K	–	814
2025 Q3	$273K	Buy	+11,696	New	+$336K	0.15%	282

Other funds holding GRPN

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGIC

Continental General Insurance Company Austin, Texas $693M AUM 90.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Windward Management Miami Beach, Florida $130M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GECH

Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's GRPN Position: Q4 2025 in Review

PharVision Advisers sold out of Groupon (GRPN) in Q4 2025, closing a stake of 11,696 shares — an estimated $273K sold.

PharVision Advisers first reported a position in GRPN in Q3 2025 and held it in 1 quarter. The position peaked at $273K in Q3 2025. 151 funds tracked by Wall St. Rank hold GRPN as of Q4 2025.

PharVision Advisers reported no remaining Groupon position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 11,696 Groupon shares in Q4 2025, an estimated $273K.
PharVision Advisers first reported a position in Groupon in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Groupon position peaked at $273K in Q3 2025.
151 funds tracked by Wall St. Rank held Groupon as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.